Faslodex International Observational Non-Interventional Study in Advanced Breast Cancer (BC) - FIONA
Study identifier:NIS-OAT-FAS-2009/1
ClinicalTrials.gov identifier:N/A
EudraCT identifier:N/A
CTIS identifier:N/A
Study Complete
Official Title
Faslodex International Observational Non-Interventional Study in Advanced Breast Cancer
Medical condition
Breast Cancer
Phase
-
Healthy volunteers
No
Study drug
-
Sex
Female
Actual Enrollment
57
Study type
Observational
Age
N/A
Date
Study Start Date: 01 Apr 2009
Primary Completion Date: 01 Sept 2010
Study Completion Date: 01 Dec 2010
Study design
Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -
Verification:
Verified 01 Nov 2013 by AstraZeneca
Sponsors
AstraZeneca
Collaborators
-
Inclusion and exclusion criteria
Loading...
No locations available
| Arms | Assigned Interventions |
|---|---|
| 1 Patient with advanced BC, already receiving Faslodex therapy | - |
Contacts
Investigators
Principal Investigator
Guenther Steger
Medical University of Vienna
